24HourWire
News from all angles
Forbes Business
Center
Anthropic’s Drug Discovery Dreams: ‘It Is Not A Side Effort’
Anthropic’s recent purchase of one-man firm Mithril is just the tip of the spear in how it hopes to use AI to accelerate drug development as it seeks a $1.4 trillion valuation in the public markets.